Literature DB >> 29564468

[Laboratory diagnostics in transient loss of consciousness : Serum lactate compared to serum creatine kinase as diagnostic indicator for generalized tonic-clonic seizures].

M Dafotakis1, J Heckelmann1, S Zechbauer1, J Litmathe1, J Brokmann2, K Willmes1, R Surges1, O Matz3,4.   

Abstract

BACKGROUND: Laboratory parameters can help in the differential diagnostics of acute episodes of transient loss of consciousness. Especially serum lactate and serum creatine kinase (CK) levels may provide valuable hints to distinguish generalized tonic-clonic seizures (GTCS) from syncope.
MATERIAL AND METHODS: Serum lactate levels at admission and CK levels 10-48 h after the episodes that led to admission were compared between patients with GTCS (n = 30) and those with syncope (n = 15). In addition, sensitivity and specificity of lactate and CK as diagnostic markers for syncope and GTCS were determined.
RESULTS: The serum lactate and serum CK levels were significantly increased in patients with GTCS as compared to syncope patients (serum lactate: p < 0.001; CK: p < 0.005). The area under the curve (AUC) for serum lactate as an indicator for GTCS was 0.94 (95% confidence interval [CI] 0.88-1.0). For CK the receiver operating characteristics (ROC) analysis produced an AUC of only 0.77 (95% CI: 0.63-0.9).
CONCLUSION: The determination of the lactate value as point-of-care diagnostics appears to be highly relevant in the rapid clarification of unclear episodes with transient loss of consciousness. The CK level at follow-up is also suitable for distinguishing GTCS from syncope but is inferior to the serum lactate value.

Entities:  

Keywords:  Creatine kinase; Epilepsy; Lactate; Syncope; Transient loss of consciousness

Mesh:

Substances:

Year:  2018        PMID: 29564468     DOI: 10.1007/s00115-018-0505-5

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  19 in total

1.  [Serum creatine kinase in the diagnosis of myocardial infarct].

Authors:  J C DREYFUS; G SCHAPIRA; J RESNAIS; L SCEBAT
Journal:  Rev Fr Etud Clin Biol       Date:  1960-04

2.  Index for rating diagnostic tests.

Authors:  W J YOUDEN
Journal:  Cancer       Date:  1950-01       Impact factor: 6.860

3.  Effects of cardiogenic shock on lactate and glucose metabolism after heart surgery.

Authors:  R L Chioléro; J P Revelly; X Leverve; P Gersbach; M C Cayeux; M M Berger; L Tappy
Journal:  Crit Care Med       Date:  2000-12       Impact factor: 7.598

4.  The meaning and use of the area under a receiver operating characteristic (ROC) curve.

Authors:  J A Hanley; B J McNeil
Journal:  Radiology       Date:  1982-04       Impact factor: 11.105

5.  Does ethanol explain the acidosis commonly seen in ethanol-intoxicated patients?

Authors:  Shahriar Zehtabchi; Richard Sinert; Bonny J Baron; Lorenzo Paladino; Kabir Yadav
Journal:  Clin Toxicol (Phila)       Date:  2005       Impact factor: 4.467

6.  Metabolic acidosis in the alcoholic: a pathophysiologic approach.

Authors:  M L Halperin; M Hammeke; R G Josse; R L Jungas
Journal:  Metabolism       Date:  1983-03       Impact factor: 8.694

7.  Relationships between markers of inflammation, severity of injury, and clinical outcomes in hemorrhagic shock.

Authors:  Sule Akkose; A Ozgurer; M Bulut; O Koksal; F Ozdemír; H Ozguç
Journal:  Adv Ther       Date:  2007 Sep-Oct       Impact factor: 3.845

8.  Postictal elevation of serum creatine kinase level.

Authors:  A L Chesson; E J Kasarskis; V W Small
Journal:  Arch Neurol       Date:  1983-05

9.  Seizure vs. syncope: measuring serum creatine kinase in the emergency department.

Authors:  M D Libman; L Potvin; L Coupal; S A Grover
Journal:  J Gen Intern Med       Date:  1991 Sep-Oct       Impact factor: 5.128

10.  Laboratory markers of cardiac and metabolic complications after generalized tonic-clonic seizures.

Authors:  Robert D Nass; Sina Meiling; René P Andrié; Christian E Elger; Rainer Surges
Journal:  BMC Neurol       Date:  2017-09-19       Impact factor: 2.474

View more
  1 in total

Review 1.  Experimental Therapeutic Strategies in Epilepsies Using Anti-Seizure Medications.

Authors:  Fakher Rahim; Reza Azizimalamiri; Mehdi Sayyah; Alireza Malayeri
Journal:  J Exp Pharmacol       Date:  2021-03-11
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.